Camden National Corporation (CAC)
Official siteFINANCIAL SERVICES • BANKS - REGIONAL • NASDAQ
Market Cap: $1.00B
Last updated: Nov 17, 2026 at 11:04 AM ET
Camden National Corporation (CAC) Stock Forecast
Analysts expect Camden National (CAC) to earn $5.39 per share in the fiscal year ending Dec 31, 2026, on revenue of $270.53M. Of 5 analysts, 1 rates the stock Buy or Strong Buy, 4 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 2 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 5 ratings average 2.60, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 20% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 20.0% |
| Buy | 0 | 0.0% |
| Hold | 4 | 80.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 5
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 6.5% and revenue estimates rise 4.8%.
- Fiscal year ending Dec 31, 2026
- $5.39
- EPS consensus, revenue $270.53M
- Fiscal year ending Dec 31, 2027
- $5.74
- EPS consensus, revenue $283.57M
- Next report
- Jan 25, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $5.39 | $5.36 to $5.44 | 5 | $270.53M | $270.10M to $271.00M | 3 |
| Dec 31, 2027 | $5.74 | $5.68 to $5.80 | 5 | $283.57M | $282.40M to $285.00M | 3 |
Quarterly Estimates
The EPS consensus falls from $1.43 for the quarter ending Dec 31, 2026 to $1.35 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.43 | $1.35 to $1.52 | 5 | $69.51M | $66.35M to $73.44M | 3 |
| Mar 31, 2027 | $1.35 | $1.32 to $1.38 | 5 | $68.35M | $68.30M to $68.40M | 2 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 3 upward and 2 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 2 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
| Quarter ending Mar 31, 2027 | 2 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 0.2% from $5.40.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $5.39 | $5.35 | $5.38 | $5.40 | $5.40 | -0.1% |
| Fiscal year ending Dec 31, 2027 | $5.74 | $5.69 | $5.74 | $5.80 | $5.80 | -1.0% |
| Quarter ending Mar 31, 2027 | $1.35 | $1.33 | $1.34 | $1.35 | $1.35 | +0.1% |
Frequently Asked Questions About CAC
What is the CAC stock forecast?
Consensus analyst estimates put Camden National's EPS at $5.39 for the fiscal year ending Dec 31, 2026, on revenue of $270.53M. The consensus rating from 5 analysts is Hold.
How do analysts rate CAC stock?
Of 5 analysts covering Camden National, 1 rates it Strong Buy, 0 Buy, 4 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from CAC next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $5.39, with estimates from $5.36 to $5.44 from 5 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $5.74, with estimates from $5.68 to $5.80 from 5 analysts.
What revenue do analysts expect from Camden National next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $270.53M, with estimates from $270.10M to $271.00M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $283.57M, with estimates from $282.40M to $285.00M.
How many analysts cover CAC?
5 analysts rate Camden National stock, and 5 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
CAC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors